NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Subjects Asthma -- drug therapy Remove constraint Subjects: Asthma -- drug therapy Publication Year 2000 to 2024 Remove constraint Publication Year: <span class="from" data-blrl-begin="2000">2000</span> to <span class="to" data-blrl-end="2024">2024</span>

Search Results

1. Mepolizumab (Nucala??, GlaxoSmithKline plc.) for the treatment of severe asthma with eosinophilia: effectiveness, value, and value-based price benchmarks : final report

2. Biologic therapies for treatment of asthma associated with type 2 inflammation: effectiveness, value, and value-based price benchmarks : final evidence report

4. Tezepelumab for severe asthma: final report